参考文献/References:
[1] Horner C,Fawley W,Morris K,et al.Escherichia coli bacteraemia:2 years of prospective regional surveillance(2010~2012)[J].J Antimicrob Chemother,2014,69(1):91-100.
[2] Clinical and Laboratory.Performance standards for a-ntimicrobial susceptibility testing; 22th informational supplement[S].Wayne:PA,CLSIM100-S22,2014.
[3] Dallenne C,Da Costa A,Decre D,et al.Development of a set of multiplexPCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae[J].J Antimicrob Chemother,2010,65(3):490-495.
[4] 孙国全,王 倩,褚云卓,等.28 179例血培养病原菌分布及耐药性分析[J].微生物学杂志,2013,33(5):102-105.
Sun GQ,Wang Q,Chu YZ,et al.Pathogen distribution & drug resistance analysis from 28 179 blood cultures[J].Journal of Microbiology,2013,33(5):102-105.
[5] Ghafourian S,Sadeghifard N,Soheili S,et al.Extended spectrum beta-lactamases:definition,classification and epidemiology[J].Curr Issues Mol Biol,2015(17):11-22.
[6] Galán JC,González-Candelas F,Rolain JM,et al.Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance:from the resistome to genetic plasticity in the β-lactamases world[J].Front Microbiol,2013(4):9.
[7] Buynak JD.β-Lactamase inhibitors:a review of the pa-tent literature(2010-2013)[J].Expert Opin Ther Pat,2013,23(11):1469-1481.
[8] Oteo J,Pérez-Vázquez M,Campos J.Extended-spectrum[beta]-lactamase producing Escherichia coli:changing epidemiology and clinical impact[J].Curr Opin Infect Dis,2010,23(4):320-326.
[9] 杨小影,吴洪秋,李丽琴,等.珠海地区妇幼保健院大肠埃希菌产ESBLs的基因型研究[J].现代检验医学杂志,2014,29(4):40-42.
Yang XY,Wu HQ,Li LQ,et al.Genotypes research for E.coli producing ESBLs in Zhuhai MCH[J].Journal of Modern Laboratory Medicine,2014,29(4):40-42.
[10] 张阮章,卢月梅,胡玉华,等.血流感染大肠埃希菌和肺炎克雷伯菌的ESBLs基因分型[J].中国微生态学杂志,2013,25(7):632-633,636.
Zhang RZ,Lu YM,Hu YH,et al.Genotyping of ESBLs in Escherichia coliand Klebsiella pneumoniae isolates from blood culture specimens[J].Chinese Journal of Microecology,2013,25(7):632-633,636.
相似文献/References:
[1]谢娜,饶国洲,朱勇,等.单极射频低温等离子体杀菌的实验研究[J].现代检验医学杂志,2015,30(05):87.[doi:10.3969/j.issn.1671-7414.2015.05.026]
XIE Na,RAO Guo-zhou,ZHU Yong,et al.Experimental Study on Monopole Radio Frequency Low
Temperature Plasma Sterilization[J].Journal of Modern Laboratory Medicine,2015,30(01):87.[doi:10.3969/j.issn.1671-7414.2015.05.026]
[2]严海忠,王 娟,卢兰芬,等.糖尿病患者感染产ESBLs肠杆菌科细菌的耐药性及危险因素分析[J].现代检验医学杂志,2018,33(05):82.[doi:10.3969/j.issn.1671-7414.2018.05.022]
YAN Hai-zhong,WANG Juan,LU Lan-fen,et al.Analysis of the Drug Resistance and Risk Factors of ESBLs-Producing Enterobacteriaceae Infection in Diabetics[J].Journal of Modern Laboratory Medicine,2018,33(01):82.[doi:10.3969/j.issn.1671-7414.2018.05.022]
[3]何家花,汪 阔,余成强.血流感染产超广谱 β-内酰胺酶大肠埃希菌的药敏结果及感染危险因素分析[J].现代检验医学杂志,2021,36(01):128.[doi:10.3969/j.issn.1671-7414.2021.01.032]
HE Jia-hua,WANG Kuo,YU Cheng-qiang.Drug Sensitivity and Risk Factors Analysis of Escherichia Coli Producing Extended-spectrum β-lactamases by Bloodstream Infection[J].Journal of Modern Laboratory Medicine,2021,36(01):128.[doi:10.3969/j.issn.1671-7414.2021.01.032]
[4]谈 昀,丁晓勇,白 晓.产β-内酰胺酶大肠埃希菌的临床分布及耐药性分析[J].现代检验医学杂志,2015,30(02):74.[doi:10.3969/j.issn.1671-7414.2015.02.023]
TAN Yun,DING Xiao-yong,BAI Xiao.Clinical Distribution and Drug-resistance
Analysis of 1 587 Escherichia coli[J].Journal of Modern Laboratory Medicine,2015,30(01):74.[doi:10.3969/j.issn.1671-7414.2015.02.023]